Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination
Abstract In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes, challenges, and future directions f...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Infectious Diseases and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s40121-025-01166-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849332544478117888 |
|---|---|
| author | Jessica Presa Ruth Carrico Jaime E. Fergie Stephanie Hanenberg Gary S. Marshall Kaitlyn Rivard Jana Shaw Gregory D. Zimet Paula Peyrani Alejandro Cane |
| author_facet | Jessica Presa Ruth Carrico Jaime E. Fergie Stephanie Hanenberg Gary S. Marshall Kaitlyn Rivard Jana Shaw Gregory D. Zimet Paula Peyrani Alejandro Cane |
| author_sort | Jessica Presa |
| collection | DOAJ |
| description | Abstract In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes, challenges, and future directions for the US meningococcal vaccination program are summarized. Current vaccination recommendations target adolescents/young adults (AYA), who are at increased risk of IMD. Suboptimal vaccination rates, particularly for meningococcal serogroup B disease, may stem from gaps in knowledge surrounding IMD and meningococcal vaccination among healthcare providers (HCPs), parents, and AYA; confusion among HCPs regarding the shared clinical decision-making recommendation for serogroup B vaccinations; demographic variables; and lack of preventive healthcare visits. ARTEMIS proposed strategies to address knowledge gaps and access barriers at the HCP, parent/AYA, and educational institution/policymaker levels. Alternative vaccination schedules using a recently approved MenABCWY vaccine that provides protection against all five major serogroups may simplify meningococcal vaccination and increase coverage. |
| format | Article |
| id | doaj-art-8c0f9f47a5794c40a3374dd3a6951a4e |
| institution | Kabale University |
| issn | 2193-8229 2193-6382 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Adis, Springer Healthcare |
| record_format | Article |
| series | Infectious Diseases and Therapy |
| spelling | doaj-art-8c0f9f47a5794c40a3374dd3a6951a4e2025-08-20T03:46:11ZengAdis, Springer HealthcareInfectious Diseases and Therapy2193-82292193-63822025-06-011471381140310.1007/s40121-025-01166-7Preventing Meningococcal Disease in US Adolescents and Young Adults Through VaccinationJessica Presa0Ruth Carrico1Jaime E. Fergie2Stephanie Hanenberg3Gary S. Marshall4Kaitlyn Rivard5Jana Shaw6Gregory D. Zimet7Paula Peyrani8Alejandro Cane9Vaccines and Antivirals, Pfizer IncDivision of Infectious Diseases, University of LouisvillePediatric Infectious Diseases Service, Driscoll Children’s HospitalWellness Center, University of ColoradoNorton Children’s and the University of Louisville School of MedicineDepartment of Pharmacy, Cleveland ClinicDepartment of Pediatrics, Division of Infectious Diseases, State University of New York Upstate Medical UniversityDepartment of Pediatrics, Indiana University School of MedicineVaccines and Antivirals, Pfizer IncVaccines and Antivirals, Pfizer IncAbstract In 2022, experts convened under the name Advancing Strategies to Prevent Meningococcal Disease (ARTEMIS) to gather insights on issues related to invasive meningococcal disease (IMD) and meningococcal vaccination in the US. Discussions regarding successes, challenges, and future directions for the US meningococcal vaccination program are summarized. Current vaccination recommendations target adolescents/young adults (AYA), who are at increased risk of IMD. Suboptimal vaccination rates, particularly for meningococcal serogroup B disease, may stem from gaps in knowledge surrounding IMD and meningococcal vaccination among healthcare providers (HCPs), parents, and AYA; confusion among HCPs regarding the shared clinical decision-making recommendation for serogroup B vaccinations; demographic variables; and lack of preventive healthcare visits. ARTEMIS proposed strategies to address knowledge gaps and access barriers at the HCP, parent/AYA, and educational institution/policymaker levels. Alternative vaccination schedules using a recently approved MenABCWY vaccine that provides protection against all five major serogroups may simplify meningococcal vaccination and increase coverage.https://doi.org/10.1007/s40121-025-01166-7AdolescentsHealthcare providersInvasive meningococcal diseaseMenABCWY vaccinePublic health policyShared clinical decision-making |
| spellingShingle | Jessica Presa Ruth Carrico Jaime E. Fergie Stephanie Hanenberg Gary S. Marshall Kaitlyn Rivard Jana Shaw Gregory D. Zimet Paula Peyrani Alejandro Cane Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination Infectious Diseases and Therapy Adolescents Healthcare providers Invasive meningococcal disease MenABCWY vaccine Public health policy Shared clinical decision-making |
| title | Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination |
| title_full | Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination |
| title_fullStr | Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination |
| title_full_unstemmed | Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination |
| title_short | Preventing Meningococcal Disease in US Adolescents and Young Adults Through Vaccination |
| title_sort | preventing meningococcal disease in us adolescents and young adults through vaccination |
| topic | Adolescents Healthcare providers Invasive meningococcal disease MenABCWY vaccine Public health policy Shared clinical decision-making |
| url | https://doi.org/10.1007/s40121-025-01166-7 |
| work_keys_str_mv | AT jessicapresa preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT ruthcarrico preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT jaimeefergie preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT stephaniehanenberg preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT garysmarshall preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT kaitlynrivard preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT janashaw preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT gregorydzimet preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT paulapeyrani preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination AT alejandrocane preventingmeningococcaldiseaseinusadolescentsandyoungadultsthroughvaccination |